Eli Lilly secures victory before Federal Circuit

29-04-2019

Eli Lilly secures victory before Federal Circuit

Jonathan Weiss / Shutterstock.com

The US Court of Appeals for the Federal Circuit affirmed a series of Patent Trial and Appeal Board (PTAB) inter partes reviews (IPRs), which upheld a patent owned by Eli Lilly late last week.


Eli Lilly, PTAB, Alimta, chemotherapy, Neptune Generics, Mylan, Fresenius Kabi, US Court of Appeals for the Federal Circuit, IPRs

LSIPR